Characteristics Influencing the Prevention of Psoriatic Arthritis With Secukinumab in Patients With Moderate to Severe Plaque Psoriasis: 5-Year Real-World Results From the SERENA Study
Authors
Augustin M, Kiltz U, Sfikakis P, Gullick N, Lespessailles E, Jürgens JB, et al.
Journal
Journal of the American Academy of Dermatology 95(1), AB93
Characteristics Influencing the Prevention of Psoriatic Arthritis With Secukinumab in Patients With Moderate to Severe Plaque Psoriasis: 5-Year Real-World Results From the SERENA Study - Publication by Dr. Andreas Clemens | Dr. Andreas Clemens